To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CTSL2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
206 supporting clones for gene CTSL2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK312806 testis .a 1 to 1051 2 to 1052 G136V tiling clone,   1052/1052
(100 %)
1 diff
(100.0 %id)
DB079265 testis .a 1 to 575 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DR158850 human embryonic stem cells differentiated toan early endodermal cell type .a 103 to 878 1 to 776       776/776
(100 %)
1 diff
(99.9 %id)
BI089784 cervix .a 104 to 969 1 to 868       868/875
(99 %)
17 diff
(98.1 %id)
CX785688 human embryonic stem cells .a 143 to 897 1 to 755   tiling clone,   755/755
(100 %)
0 diff
(100 %id)
CN369086 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 150 to 873 1 to 724       724/724
(100 %)
3 diff
(99.6 %id)
AA847436 colon, colon tumor .a 168 to 621 1 to 454       454/454
(100 %)
2 diff
(99.6 %id)
AY358641   .b 1 to 1547 1 to 1547 exact tiling clone,   1547/1547
(100 %)
1 diff
(100.0 %id)
NM_001333.2   .b 54 to 1549 1 to 1496 exact RefSeq,   1496/1496
(100 %)
0 diff
(100 %id)
BC110512 PCR rescued clones .b 132 to 1339 1 to 1208 exact     1208/1209
(99 %)
1 diff
(100.0 %id)
BP194225 brain .b 145 to 722 1 to 582       582/582
(100 %)
16 diff
(97.3 %id)
BP248845 Kidney .b 145 to 727 1 to 582       582/582
(100 %)
10 diff
(98.3 %id)
AU310402 neuroblastoma .b 161 to 747 14 to 600       587/600
(97 %)
5 diff
(99.2 %id)
BU561568 testis .b 166 to 646 1 to 481       481/894
(53 %)
5 diff
(99.5 %id)
BU929868 placenta .b 166 to 870 1 to 712       712/769
(92 %)
26 diff
(96.7 %id)
DN916901   .b 169 to 764 33 to 627       595/627
(94 %)
9 diff
(98.6 %id)
BP355230   .b 169 to 750 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP366443 thymus .b 169 to 749 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BP366778 thymus .b 169 to 750 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
BP368026 thymus .b 169 to 749 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP371074 testis .b 169 to 759 1 to 587       587/587
(100 %)
5 diff
(99.2 %id)
DA452625 tongue, tumor tissue .b 170 to 727 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BG433370 Kidney .b 170 to 749 1 to 591       567/591
(95 %)
26 diff
(95.7 %id)
DB064738 testis .b 170 to 663 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
DB148616 thymus .b 170 to 633 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
AL706083 human skeletal muscle .b 171 to 748 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
BG432691 Kidney .b 171 to 872 1 to 701       701/732
(95 %)
8 diff
(99.0 %id)
BG433961 Kidney .b 171 to 1038 1 to 871       871/888
(98 %)
30 diff
(96.7 %id)
BP199741 brain .b 172 to 754 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CD698519 normal nasopharynx .b 172 to 656 32 to 516       485/516
(93 %)
10 diff
(98.1 %id)
AL706075 human skeletal muscle .b 172 to 672 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
BP228502   .b 172 to 752 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DN917792   .b 172 to 707 32 to 567       536/567
(94 %)
6 diff
(99.0 %id)
DN919553   .b 172 to 818 32 to 673       642/673
(95 %)
12 diff
(98.3 %id)
DW432608 Liver .b 172 to 418 18 to 265       248/265
(93 %)
15 diff
(94.4 %id)
BP353835   .b 172 to 645 1 to 474       474/581
(81 %)
2 diff
(99.7 %id)
DA458819 tongue, tumor tissue .b 173 to 737 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB110381 thymus .b 173 to 674 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
DB110779 thymus .b 173 to 674 2 to 503   capped   502/502
(100 %)
1 diff
(99.9 %id)
DB132446 thymus .b 173 to 711 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB136879 thymus .b 173 to 635 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
DB138638 thymus .b 173 to 710 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB147457 thymus .b 173 to 725 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB152925 thymus .b 173 to 747 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DB159840 thymus .b 173 to 765 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DB165207 thymus .b 173 to 725 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BP367312 thymus .b 173 to 751 1 to 579       579/579
(100 %)
0 diff
(100 %id)
CN369097 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 175 to 816 1 to 641       641/641
(100 %)
4 diff
(99.4 %id)
BG400048 Kidney .b 176 to 867 1 to 687       687/871
(78 %)
28 diff
(96.8 %id)
BM781965 myeloma .b 176 to 763 1 to 588       588/588
(100 %)
0 diff
(100 %id)
CN369090 embryonic stem cells, DMSO-treated H9 cellline .b 177 to 621 1 to 445       445/445
(100 %)
4 diff
(99.2 %id)
CV573019 cornea, eye .b 177 to 766 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BM764323 lymph node, stomach .b 177 to 737 1 to 561       561/561
(100 %)
0 diff
(100 %id)
AB001928 corneal epithelium .b 178 to 1549 1 to 1372 exact tiling clone,   1372/1372
(100 %)
0 diff
(100 %id)
BI087441 cervix .b 179 to 953 1 to 775       775/778
(99 %)
2 diff
(99.8 %id)
CX757137 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 179 to 843 1 to 664     Submitted on the opposite strand 664/729
(91 %)
18 diff
(97.6 %id)
DR423019 eye, Pterygium .b 179 to 933 1 to 754       754/754
(100 %)
7 diff
(99.1 %id)
CX166299 human embryonic stem cells differentiated toan early endodermal cell type .b 180 to 1004 1 to 825       825/825
(100 %)
5 diff
(99.4 %id)
CD557765 testis .b 182 to 1038 22 to 882       861/898
(95 %)
22 diff
(97.6 %id)
Y14734   .b 182 to 1523 1 to 1342 G81P     1342/1342
(100 %)
5 diff
(99.7 %id)
CN369081 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 183 to 945 9 to 771       763/771
(98 %)
0 diff
(100 %id)
CN369085 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 183 to 950 8 to 775       768/775
(99 %)
7 diff
(99.1 %id)
CN369088 embryonic stem cells, cell lines H1, H7, andH9 .b 183 to 446 1 to 264       264/264
(100 %)
2 diff
(99.3 %id)
CN369098 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 183 to 753 9 to 579       571/579
(98 %)
0 diff
(100 %id)
BI089450 cervix .b 183 to 947 1 to 766       766/771
(99 %)
18 diff
(97.7 %id)
CN369089 embryonic stem cells, cell lines H1, H7, andH9 .b 184 to 872 1 to 688       688/692
(99 %)
4 diff
(99.5 %id)
BX352998 Neuroblastoma Cot 10-normalized .b 184 to 953 1 to 769       769/769
(100 %)
1 diff
(99.9 %id)
BG767099 melanotic melanoma, high MDR (cell line), skin .b 184 to 998 1 to 821       821/821
(100 %)
9 diff
(99.0 %id)
BG681035 skin, squamous cell carcinoma .b 185 to 901 1 to 717       717/717
(100 %)
2 diff
(99.8 %id)
BQ945562 carcinoma, cell line, Prostate .b 185 to 831 38 to 697       660/1009
(65 %)
26 diff
(97.5 %id)
CX163885 human embryonic stem cells differentiated toan early endodermal cell type .b 185 to 1033 1 to 849       849/849
(100 %)
0 diff
(100 %id)
CV573979 cornea, eye .b 185 to 824 1 to 640       640/640
(100 %)
0 diff
(100 %id)
BC023504 Placenta, choriocarcinoma .b 187 to 1371 1 to 1185 exact available from MGC, AAA   1185/1436
(82 %)
1 diff
(100.0 %id)
CN369101 embryonic stem cells, DMSO-treated H9 cellline .b 187 to 639 9 to 461       453/461
(98 %)
6 diff
(98.7 %id)
CV573443 cornea, eye .b 187 to 767 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CV574865 cornea, eye .b 187 to 823 1 to 637       637/637
(100 %)
0 diff
(100 %id)
DN992586 brain, whole brain .b 187 to 809 8 to 630       623/630
(98 %)
6 diff
(99.1 %id)
CX759568 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 188 to 872 1 to 684     Submitted on the opposite strand 684/825
(82 %)
13 diff
(98.5 %id)
DR156645 human embryonic stem cells differentiated toan early endodermal cell type .b 188 to 1009 1 to 822       822/822
(100 %)
0 diff
(100 %id)
AA298106   .b 189 to 473 1 to 289       289/293
(98 %)
7 diff
(97.7 %id)
BE018612 cervix .b 190 to 756 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
BF105049 Kidney .b 190 to 646 1 to 462       462/862
(53 %)
8 diff
(99.1 %id)
BE565386 bladder, carcinoma, cell line .b 191 to 878 1 to 672       674/865
(77 %)
27 diff
(96.9 %id)
BG335755 choriocarcinoma, placenta .b 191 to 872 1 to 675       677/922
(73 %)
17 diff
(98.2 %id)
AL046189 testis .b 192 to 685 1 to 494       494/495
(99 %)
1 diff
(99.8 %id)
BE734923 choriocarcinoma, placenta .b 192 to 1038 38 to 885       848/1051
(80 %)
31 diff
(97.1 %id)
DR157250 human embryonic stem cells differentiated toan early endodermal cell type .b 192 to 925 1 to 734       734/734
(100 %)
0 diff
(100 %id)
CV569672 cornea, eye .b 192 to 802 1 to 611       611/611
(100 %)
0 diff
(100 %id)
CN369080 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 197 to 777 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CN369082 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 198 to 637 1 to 440       440/440
(100 %)
2 diff
(99.6 %id)
CN369094 embryonic stem cells, DMSO-treated H9 cellline .b 198 to 698 1 to 502       502/502
(100 %)
1 diff
(99.9 %id)
CN369095 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 198 to 621 1 to 424       424/424
(100 %)
0 diff
(100 %id)
CN369092 embryonic stem cells, cell lines H1, H7, andH9 .b 199 to 844 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
BE902510 choriocarcinoma, placenta .b 202 to 1027 1 to 822       822/867
(94 %)
23 diff
(97.4 %id)
BE280701 choriocarcinoma, placenta .b 208 to 845 1 to 635       637/635
(100 %)
5 diff
(99.3 %id)
BP423833 small intestine .b 209 to 668 1 to 460     Submitted on the opposite strand 460/460
(100 %)
0 diff
(100 %id)
AF070448   .b 224 to 1401 1 to 1178 exact     1178/1178
(100 %)
3 diff
(99.8 %id)
AA307011 colon .b 227 to 585 1 to 359       359/359
(100 %)
0 diff
(100 %id)
DR156893 human embryonic stem cells differentiated toan early endodermal cell type .b 763 to 1546 797 to 14   AAA Submitted on the opposite strand 784/784
(100 %)
1 diff
(99.9 %id)
BM559972 brain, medulla .b 786 to 1546 11 to 770       760/775
(98 %)
7 diff
(99.1 %id)
BU619955 cell lines, Chondrosarcoma .b 821 to 1546 740 to 17   AAA   724/724
(100 %)
2 diff
(99.8 %id)
AA235781 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 841 to 1091 1 to 253       253/257
(98 %)
24 diff
(90.7 %id)
CN369091 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 848 to 1546 1 to 699   AAA   699/699
(100 %)
3 diff
(99.6 %id)
BE965331 epithelioid carcinoma, Pancreas .b 897 to 1546 684 to 17   AAA   668/668
(100 %)
52 diff
(92.3 %id)
DN916900   .b 944 to 1540 596 to 1       596/596
(100 %)
3 diff
(99.5 %id)
AI814383 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 945 to 1547 604 to 1       604/604
(100 %)
9 diff
(98.6 %id)
AW450930   .b 990 to 1528 551 to 13   AAA   539/539
(100 %)
0 diff
(100 %id)
BE302200 cervix .b 1002 to 1543 544 to 3       542/544
(99 %)
2 diff
(99.7 %id)
AU310403 neuroblastoma .b 1016 to 1546 546 to 16   AAA   531/531
(100 %)
1 diff
(99.9 %id)
AA235364 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1112 to 1546 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AA868148   .b 1136 to 1549 414 to 1       414/414
(100 %)
4 diff
(99.1 %id)
AI368960 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 1144 to 1542 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AI867566 pooled germ cell tumors .b 1147 to 1542 396 to 1       396/396
(100 %)
0 diff
(100 %id)
CK906127 Islets of Langerhans, Pancreas .b 1148 to 1546 1 to 399   AAA   399/399
(100 %)
0 diff
(100 %id)
BX350803 Neuroblastoma Cot 10-normalized .b 1153 to 1543 389 to 1       389/913
(42 %)
10 diff
(99.0 %id)
BG400297 Kidney .c 1 to 811 1 to 813   tiling clone,   813/816
(99 %)
48 diff
(94.2 %id)
CA417449 Chondrosarcoma Cell line .c 612 to 1373 777 to 17   tiling clone, AAA   761/761
(100 %)
3 diff
(99.7 %id)
CD244059 testis .d 1 to 833 1 to 841   tiling clone, available from MGC,   841/869
(96 %)
13 diff
(98.6 %id)
BC067289 testis .d 6 to 2102 1 to 2097 exact tiling clone, available from MGC, AAA   2097/2097
(100 %)
0 diff
(100 %id)
CV393955 breast_normal .d 735 to 910 179 to 7     Submitted on the opposite strand 173/179
(96 %)
0 diff
(100 %id)
CN369087 embryonic stem cells, cell lines H1, H7, andH9 .d 937 to 1708 1 to 772       772/772
(100 %)
4 diff
(99.5 %id)
CB156052 Liver .d 937 to 1493 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BP228038   .d 938 to 1429 1 to 492       492/550
(89 %)
16 diff
(97.1 %id)
BG679304 skin, squamous cell carcinoma .d 1012 to 1926 1 to 933       933/933
(100 %)
21 diff
(97.8 %id)
DB154683 thymus .d 1053 to 1606 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
TI_154128425   .d 1121 to 2102 1045 to 85   AAA   964/982
(98 %)
31 diff
(96.9 %id)
BQ317788 colon .d 1160 to 1792 15 to 640       626/641
(97 %)
27 diff
(95.8 %id)
BQ354305 head_neck .d 1197 to 1471 1 to 278       280/278
(100 %)
8 diff
(97.2 %id)
BQ354311 head_neck .d 1197 to 1471 1 to 278       280/278
(100 %)
8 diff
(97.2 %id)
BG698510 skin .d 1207 to 1694 13 to 500       487/503
(96 %)
7 diff
(98.7 %id)
BI092998 cervix .d 1245 to 1972 1 to 733       733/733
(100 %)
8 diff
(99.0 %id)
CV329552 uterus .d 1251 to 1503 1 to 253       253/253
(100 %)
3 diff
(98.9 %id)
BQ377510 uterus .d 1257 to 1663 407 to 1       407/407
(100 %)
4 diff
(99.1 %id)
DB134834 thymus .d 1259 to 1817 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
BQ312078 breast_normal .d 1375 to 1829 1 to 456       456/467
(97 %)
5 diff
(99.0 %id)
CN369093 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1379 to 1670 1 to 292       292/292
(100 %)
3 diff
(99.0 %id)
BM852345 Ascites, stomach .d 1385 to 1861 1 to 477       477/477
(100 %)
0 diff
(100 %id)
CN369096 embryonic stem cells, DMSO-treated H9 cellline .d 1394 to 1917 1 to 524       524/524
(100 %)
0 diff
(100 %id)
CV381259 uterus_tumor .d 1455 to 1833 380 to 1     Submitted on the opposite strand 380/386
(98 %)
10 diff
(97.5 %id)
CV381282 uterus_tumor .d 1455 to 1833 380 to 1     Submitted on the opposite strand 380/386
(98 %)
10 diff
(97.5 %id)
BU597224 mixed (pool of 40 RNAs) .d 1500 to 2102 1 to 603   AAA   603/603
(100 %)
3 diff
(99.6 %id)
AI686909 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1501 to 2102 602 to 1       602/602
(100 %)
1 diff
(99.9 %id)
AI627737 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1501 to 2100 600 to 1       600/600
(100 %)
2 diff
(99.7 %id)
AI950810 lung, two pooled squamous cell carcinomas .d 1506 to 2102 597 to 1       597/597
(100 %)
3 diff
(99.5 %id)
AU149904.
matches multiple genes
  .d 1527 to 2102 578 to 1     also hits gene PIK3R3 578/580
(99 %)
16 diff
(97.3 %id)
DN917793   .d 1546 to 2097 553 to 2       552/553
(99 %)
1 diff
(99.9 %id)
AA554362 germ cell tumor .d 1551 to 2101 544 to 1       544/544
(100 %)
7 diff
(98.8 %id)
BP228144   .d 1557 to 2102 1 to 546   AAA   546/546
(100 %)
0 diff
(100 %id)
DN919552   .d 1560 to 2101 543 to 2       542/543
(99 %)
0 diff
(100 %id)
AA758169   .d 1591 to 2102 513 to 1       513/513
(100 %)
6 diff
(98.9 %id)
AW512660 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1608 to 2102 493 to 1       493/493
(100 %)
3 diff
(99.4 %id)
AI803574 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1625 to 2100 476 to 1       476/476
(100 %)
0 diff
(100 %id)
AA565512 germ cell tumor .d 1650 to 2098 446 to 1       446/461
(96 %)
7 diff
(98.5 %id)
AI654116 Kidney .d 1654 to 2096 451 to 8       444/451
(98 %)
0 diff
(100 %id)
AW151435 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1712 to 2102 393 to 1       393/393
(100 %)
6 diff
(98.5 %id)
AA585253   .d 1873 to 2056 181 to 1       181/181
(100 %)
5 diff
(97.3 %id)
AA170803   .d 1933 to 2075 145 to 4       142/147
(96 %)
0 diff
(100 %id)
AW487810   .d 2006 to 2085 80 to 1       80/80
(100 %)
0 diff
(100 %id)
DA455086 tongue, tumor tissue .d 2032 to 2614 2 to 584   tiling clone, capped   583/583
(100 %)
1 diff
(99.9 %id)
AW151442 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 2034 to 2102 69 to 1       69/69
(100 %)
0 diff
(100 %id)
DB146329 thymus .d 2038 to 2608 2 to 573   tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
DB162060 thymus .d 2057 to 2642 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DB120441 thymus .d 2087 to 2643 2 to 558   tiling clone, capped   557/557
(100 %)
3 diff
(99.5 %id)
AK310740 thymus .e 1 to 1459 1 to 1459 K78* tiling clone,   1459/1459
(100 %)
1 diff
(100.0 %id)
DB162406 thymus .e 2 to 590 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
CN369084 embryonic stem cells, cell lines H1, H7, andH9 .e 13 to 314 1 to 304       304/304
(100 %)
6 diff
(98.1 %id)
DB123838 thymus .e 1066 to 1702 2 to 638   tiling clone, capped   637/647
(98 %)
1 diff
(99.9 %id)
DA621056 Kidney .f 1 to 803 2 to 801   tiling clone, to resequence, capped   800/802
(99 %)
6 diff
(99.3 %id)
CN369100 embryonic stem cells, DMSO-treated H9 cellline .f 443 to 971 9 to 537   tiling clone,   529/537
(98 %)
0 diff
(100 %id)
DB320286 Kidney .f 1463 to 1974 505 to 1   tiling clone, to resequence,   505/508
(99 %)
14 diff
(97.3 %id)
BP227256   .g 1 to 581 1 to 581   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
BE735259 choriocarcinoma, placenta .g 6 to 834 4 to 833 W120X C178L N179P G180M G181V ... tiling clone,   830/972
(85 %)
26 diff
(97.4 %id)
DN601978 human embryonic stem cells .g 10 to 666 1 to 657       657/657
(100 %)
0 diff
(100 %id)
CX754804 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 17 to 747 1 to 730   tiling clone, Submitted on the opposite strand 730/731
(99 %)
2 diff
(99.8 %id)
BE535925 cervix .g 33 to 810 1 to 780   tiling clone,   782/805
(97 %)
46 diff
(94.3 %id)
AK310645 thymus .h 1 to 1342 1 to 1342 L57P tiling clone,   1342/1342
(100 %)
1 diff
(100.0 %id)
DB138574 thymus .h 2 to 533 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
BM764331 lymph node, stomach .i 1 to 504 2 to 505       505/505
(100 %)
0 diff
(100 %id)
BM843816 lymph node, stomach .i 1 to 519 2 to 519       519/519
(100 %)
1 diff
(99.9 %id)
BM850210 lymph node, stomach .i 1 to 576 2 to 577 exact tiling clone,   577/577
(100 %)
0 diff
(100 %id)
BM851323 lymph node, stomach .i 1 to 402 2 to 403       403/403
(100 %)
1 diff
(99.8 %id)
CV570241 cornea, eye .j 1 to 591 12 to 602   tiling clone,   591/591
(100 %)
0 diff
(100 %id)
CN369099 embryonic stem cells, DMSO-treated H9 cellline .j 10 to 778 1 to 770 I61N V63C P64S N65K Q66S ... tiling clone,   770/770
(100 %)
5 diff
(99.4 %id)
BE001000 breast_normal .j 254 to 601 14 to 360       347/378
(91 %)
7 diff
(98.2 %id)
BE000946 breast_normal .j 280 to 601 1 to 322       322/340
(94 %)
5 diff
(98.6 %id)
BC043374 Brain, adult medulla .k 1 to 2260 1 to 2260 H140R tiling clone, available from MGC, AAA   2260/2260
(100 %)
4 diff
(99.9 %id)
BI831266 brain, medulla .k 1 to 639 1 to 650   available from MGC,   650/666
(97 %)
25 diff
(96.3 %id)
TI_57176944   .k 1 to 639 70 to 719       650/735
(88 %)
29 diff
(96.1 %id)
NR_002942.1   .k 1 to 2260 1 to 2260 H140R RefSeq, AAA   2260/2260
(100 %)
4 diff
(99.9 %id)
DB106587 thymus .l 1 to 557 2 to 558 exact tiling clone, to resequence, capped   557/557
(100 %)
1 diff
(99.9 %id)
DB342962 thymus .l 1225 to 1800 576 to 1   tiling clone, to resequence,   576/576
(100 %)
1 diff
(99.9 %id)
BX404824 thymus .m 1 to 1108 1 to 1106 exact tiling clone,   1106/1106
(100 %)
11 diff
(99.1 %id)
BX436450 thymus .m 1 to 874 1 to 858 exact     858/903
(95 %)
25 diff
(97.3 %id)
BX447324 thymus .m 1 to 1088 1 to 1077 exact tiling clone,   1077/1117
(96 %)
17 diff
(98.5 %id)
DB136738 thymus .n-u 1 to 556 2 to 557 exact tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DB164219 thymus .n-u 61 to 641 2 to 584 exact capped   583/583
(100 %)
3 diff
(99.5 %id)
DB159938 thymus .n-u 138 to 741 2 to 605 exact tiling clone, capped   604/604
(100 %)
0 diff
(100 %id)
CB960028 Human Placenta, placenta .o 1 to 632 28 to 661 exact tiling clone,   634/797
(79 %)
9 diff
(98.9 %id)
DW448835 Liver .p -9 to 137 9 to 155   tiling clone, AAA   147/155
(94 %)
6 diff
(96.2 %id)
BP367303 thymus .p 3 to 532 1 to 530 exact     530/583
(90 %)
12 diff
(98.0 %id)
DA124547 cerebellum .p 4 to 561 2 to 559 exact capped   558/558
(100 %)
0 diff
(100 %id)
CV572037 cornea, eye .p 16 to 586 1 to 571 exact tiling clone,   571/571
(100 %)
0 diff
(100 %id)
AW997012 breast_normal .q-u 1 to 542 1 to 544 exact tiling clone,   544/544
(100 %)
7 diff
(98.8 %id)
AI652005 pooled germ cell tumors .r-u 1 to 474 479 to 6 exact tiling clone,   474/479
(98 %)
0 diff
(100 %id)
BM127507 Islets of Langerhans, Pancreas .r-u 89 to 474 1 to 386       386/391
(98 %)
1 diff
(99.8 %id)
BM127639 Islets of Langerhans, Pancreas .r-u 89 to 474 1 to 386   fully sequenced,   386/386
(100 %)
1 diff
(99.8 %id)
BM127218 Islets of Langerhans, Pancreas .r-u 119 to 474 357 to 2       356/357
(99 %)
0 diff
(100 %id)
BX097805 ovarian tumor, ovary .r-u 125 to 471 1 to 346   AAA   346/346
(100 %)
1 diff
(99.8 %id)
AA478227 ovarian tumor, ovary .r-u 125 to 471 14 to 359   fully sequenced,   346/359
(96 %)
6 diff
(98.4 %id)
AA477829 ovarian tumor, ovary .r-u 203 to 472 269 to 1   fully sequenced,   269/269
(100 %)
1 diff
(99.7 %id)
CA502944 Human Lung Epithelial cells, lung .r-u 242 to 471 246 to 17   AAA   230/230
(100 %)
1 diff
(99.6 %id)
BM127334 Islets of Langerhans, Pancreas .r-u 282 to 475 194 to 1   fully sequenced,   194/194
(100 %)
1 diff
(99.5 %id)
C00486   .r-u 290 to 471 1 to 183       183/183
(100 %)
1 diff
(99.5 %id)
BX436550 thymus Gene CTSL2, variant not shown         This clone was ignored    
BX436551 thymus Gene CTSL2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o, .p, .q-u, .r-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC